Comparison of the clinical features and hematopoietic stem cell transplantation outcomes of mediastinal malignant germ cell tumors with nonmediastinal extragonadal placements
- PMID: 28003760
- PMCID: PMC5158173
- DOI: 10.2147/OTT.S107899
Comparison of the clinical features and hematopoietic stem cell transplantation outcomes of mediastinal malignant germ cell tumors with nonmediastinal extragonadal placements
Abstract
Objective: Even though the primary mediastinal extragonadal germ cell tumors (EGCTs) are rare, they are noteworthy in the differential diagnosis of mediastinal masses. In this study, we aimed to identify the clinical features of mediastinal malignant GCTs and compare the results of hematopoietic stem cell transplantation between mediastinal and nonmediastinal malignant EGCTs.
Method: Data of the patients with EGCT who were treated and underwent hematopoietic stem cell transplantation at our hospital between 1988 and 2015 were retrieved retrospectively. Results were compared between mediastinal and nonmediastinal EGCTs.
Results: Data of 65 patients diagnosed with EGCT (37 [56.92%] cases with mediastinal EGCT and 28 [43.07%] cases with nonmediastinal EGCT) were assessed. The clinical stages, frequency of pretransplant status, mean pretransplant time, and mean number of chemotherapy lines before hematopoietic stem cell transplantation were not significantly different between groups. Although the overall survival did not significantly differ between groups, the 5-year survival was significantly higher in mediastinal EGCTs (P=0.02). Yolk sac tumor was significantly more common in mediastinal EGCTs (P=0.05). Mortality rates were higher in seminomas and yolk sac tumors in all cases, higher in embryonal carcinomas in mediastinal EGCT group and higher in yolk sac tumors in nonmediastinal EGCT group. While choriocarcinomas had more aggressive courses in mediastinal EGCTs, seminomas and yolk sac tumors had poorer prognosis in nonmediastinal EGCTs. Short pretransplant time and persistence of elevated posttransplant βhCG and AFP levels were the significant mortality risk factors both in mediastinal and nonmediastinal EGCTs.
Conclusion: Mediastinal placement of EGCT was not a poor prognostic factor; furthermore, the 5-year survival was significantly higher in mediastinal EGCTs. According to our knowledge, this is the first study that compares the clinical outcomes of hematopoietic stem cell transplantation of mediastinal and nonmediastinal malignant EGCTs.
Keywords: extragonadal germ cell tumor; hematopoietic stem cell transplantation; mediastinum; survival; tumor marker; α-fetoprotein; βhCG.
Conflict of interest statement
The authors report no conflicts of interests in this work.
Figures
Similar articles
-
How to classify, diagnose, treat and follow-up extragonadal germ cell tumors? A systematic review of available evidence.World J Urol. 2022 Dec;40(12):2863-2878. doi: 10.1007/s00345-022-04009-z. Epub 2022 May 12. World J Urol. 2022. PMID: 35554637 Free PMC article.
-
Male Extragonadal Germ Cell Tumors of the Adult.Oncol Res Treat. 2016;39(3):140-4. doi: 10.1159/000444271. Epub 2016 Feb 23. Oncol Res Treat. 2016. PMID: 27032104 Review.
-
Extragonadal germ cell tumors: A clinicopathologic study with emphasis on molecular features, clinical outcomes and associated secondary malignancies.Hum Pathol. 2024 Jun;148:41-50. doi: 10.1016/j.humpath.2024.04.015. Epub 2024 Apr 30. Hum Pathol. 2024. PMID: 38697270
-
Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors.J Natl Cancer Inst. 2001 Nov 21;93(22):1733-8. doi: 10.1093/jnci/93.22.1733. J Natl Cancer Inst. 2001. PMID: 11717334
-
Clinical Features and Treatment Outcomes in Patients with Extragonadal Germ Cell Tumors: A Single-center Experience.Anticancer Res. 2016 Jan;36(1):313-7. Anticancer Res. 2016. PMID: 26722059
Cited by
-
Pediatric mediastinal germ cell tumors.Mediastinum. 2019 Jul 22;3:30. doi: 10.21037/med.2019.07.02. eCollection 2019. Mediastinum. 2019. PMID: 35118258 Free PMC article. Review.
References
-
- Rivera C, Arame A, Jougon J, et al. Prognostic factors in patients with primary mediastinal germ cell tumors, a surgical multicenter retrospective study. Interact Cardiovasc Thorac Surg. 2010;11(5):585–589. - PubMed
-
- Takeda S, Miyoshi S, Ohta M, Minami M, Masaoka A, Matsuda H. Primary germ cell tumors in the mediastinum: a 50-year experience at a single Japanese institution. Cancer. 2003;97(2):367–376. - PubMed
-
- Caposole MZ, Aruca-Bustillo V, Mitchell M, Nam B. Benign metachronous bilateral ovarian and mediastinal teratomas with an elevated alpha-fetoprotein. Ann Thorac Surg. 2015;99(3):1073–1075. - PubMed
-
- Sarkaria IS, Bains MS, Sood S, et al. Resection of primary mediastinal non-seminomatous germ cell tumors: a 28-year experience at memorial sloan-kettering cancer center. J Thorac Oncol. 2011;6(7):1236–1241. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources